Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warming Sensation of Acetylcysteine 2% Solution in Productive Cough
NCT02822287Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of acetylcysteine in upper respiratory tract infection (URI), sponsored by GSK. Primary endpoints: Onset of Warming Sensation, Duration of Warming Sensation and 1 more. Started Feb 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT02822287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822287.